MPO: How In Silico Simulations Can Slash Medical Device Development Risk

Medical Device In Silico Simulations

The August 10, 2023 online issue of Medical Product Outsourcing (MPO) features online exclusive, How In Silico Simulations Can Slash Medical Device Development Risk, written by Muhammad Jamil, Ph.D., StarFish Computational Fluid Dynamics Engineer. Jamil discusses the use of in silico simulations in the development of medical devices to mitigate risks and improve efficiency

Jamil examines statistical data by Health Canada and the FDA on medical device incidents (MDI) and recall data to determine whether “using the tool [in silico simulations] could help minimize risk throughout the product lifecycle via multiple design iterations, at a fraction of the cost.” He then provides more detail on how in silico simulations can help improve and innovate the design process.
He ultimately concludes: “In silico simulations can form the basis of a robust development process, where different designs can be tested in short periods of time by predicting failure in advance, testing in extreme conditions, and designing bench experiments. Simulations can also be a tool to design and optimize clinical trials, greatly reducing time and costs.”

About StarFish Medical

Empowering Medtech Innovation ®
StarFish Medical is an award-winning, full-service Medical Device Design company offering design, development, and NPI manufacturing services based in Toronto and Victoria BC. Our Pathfinder™ process reduces wasted effort and increases success for medical device product definition, technical engineering, and product development. Prototype and volume production are delivered within an ISO 13485 certified Quality Management System, manufacturing and clean room facilities.

Empowering Medtech Innovation®. www.starfishmedical.com

StarFish Medical media contact:

Patrick Dean
pdean@starfishmedical.com